Literature DB >> 29508975

The Effect of Medicare Part D on Pharmaceutical Prices and Utilization.

Mark Duggan1, Fiona Scott Morton2.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 29508975     DOI: 10.1257/aer.100.1.590

Source DB:  PubMed          Journal:  Am Econ Rev        ISSN: 0002-8282


× No keyword cloud information.
  10 in total

1.  Insurers' Negotiating Leverage and the External Effects of Medicare Part D.

Authors:  Darius Lakdawalla; Wesley Yin
Journal:  Rev Econ Stat       Date:  2015-05-01

2.  The effects of state-level pharmacist regulations on generic substitution of prescription drugs.

Authors:  Yan Song; Douglas Barthold
Journal:  Health Econ       Date:  2018-07-10       Impact factor: 3.046

3.  The impact of health insurance expansion on physician treatment choice: Medicare Part D and physician prescribing.

Authors:  Tianyan Hu; Sandra L Decker; Shin-Yi Chou
Journal:  Int J Health Econ Manag       Date:  2017-02-06

4.  Market Size and Innovation: Effects of Medicare Part D on Pharmaceutical Research and Development.

Authors:  Margaret E Blume-Kohout; Neeraj Sood
Journal:  J Public Econ       Date:  2013-01

5.  How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D.

Authors:  David Powell; Rosalie Liccardo Pacula; Erin Taylor
Journal:  J Health Econ       Date:  2020-03-04       Impact factor: 3.883

6.  THE RESPONSE OF DRUG EXPENDITURE TO NON-LINEAR CONTRACT DESIGN: EVIDENCE FROM MEDICARE PART D.

Authors:  Liran Einav; Amy Finkelstein; Paul Schrimpf
Journal:  Q J Econ       Date:  2015-02-08

7.  Pharmaceutical advertising and Medicare Part D.

Authors:  Darius Lakdawalla; Neeraj Sood; Qian Gu
Journal:  J Health Econ       Date:  2013-12       Impact factor: 3.883

8.  The impact of Medicare part D on income-related inequality in pharmaceutical expenditure.

Authors:  Natalie Carvalho; Dennis Petrie; Linkun Chen; Joshua A Salomon; Philip Clarke
Journal:  Int J Equity Health       Date:  2019-04-16

9.  Beyond Statistics: The Economic Content of Risk Scores.

Authors:  Liran Einav; Amy Finkelstein; Raymond Kluender; Paul Schrimpf
Journal:  Am Econ J Appl Econ       Date:  2016-04

10.  The effect on dental care utilization from transitioning pediatric Medicaid beneficiaries to managed care.

Authors:  Kamyar Nasseh; John R Bowblis
Journal:  Health Econ       Date:  2022-03-23       Impact factor: 2.395

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.